tiprankstipranks
Trending News
More News >
Aspen Pharmacare (APNHY)
:APNHY
US Market

Aspen Pharmacare (APNHY) Income Statement

Compare
22 Followers

Aspen Pharmacare Income Statement

Last quarter (Q4 2023), Aspen Pharmacare's total revenue was Rs23.57B, an increase of 118.61% from the same quarter last year. In Q4, Aspen Pharmacare's net income was Rs2.09B. See Aspen Pharmacare’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
Rs 44.71BRs 2.29BRs 2.54BRs 2.45BRs 2.15B
Gross Profit
Rs 19.42BRs 1.02BRs 1.15BRs 1.10BRs 1.04B
Operating Expenses
Rs 12.42BRs 516.80MRs 545.81MRs 575.83MRs 552.17M
Depreciation and Amortization
Rs 1.97BRs 1.79BRs 1.71BRs 1.65BRs 1.60B
EBITDA
Rs 9.90BRs 9.67BRs 10.61BRs 8.85BRs 7.45B
Operating Income
Rs 7.00BRs 504.54MRs 605.80MRs 523.61MRs 486.94M
Other Income/Expenses
Rs -1.28BRs -1.27BRs -537.00MRs -1.08BRs -1.53B
Pretax Income
Rs 5.71BRs 368.82MRs 534.38MRs 388.54MRs 267.95M
Net Income
Rs 4.40BRs 294.16MRs 426.24MRs 286.03MRs 310.07M
Per Share Metrics
Basic EPS
Rs 9.91Rs 0.66Rs 0.94Rs 0.63Rs 0.68
Diluted EPS
Rs 9.91Rs 0.66Rs 0.94Rs 0.63Rs 0.68
Weighted Average Shares Outstanding
444.20M 444.20M 453.00M 456.50M 456.50M
Weighted Average Shares Outstanding (Diluted)
444.20M 444.20M 453.00M 456.50M 456.50M
Currency in ZAR

Aspen Pharmacare Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis